These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 301159)

  • 41. [Factor VIII (anti-hemophilic A factor). Biology, physiology, pathology and genetics].
    Meyer D; Dray L; Allain JP; Larrieu MJ
    Pathol Biol (Paris); 1972; 20(11):607-23. PubMed ID: 4558579
    [No Abstract]   [Full Text] [Related]  

  • 42. Antihemophilic factor (factor VIII).
    Ratnoff OD
    Ann Intern Med; 1978 Mar; 88(3):403-9. PubMed ID: 343683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

  • 44. The cold-insoluble globulin of plasma and its relationship to factor VIII.
    Cooper HA; Wagner RH; Mosesson MW
    J Lab Clin Med; 1974 Aug; 84(2):258-63. PubMed ID: 4135593
    [No Abstract]   [Full Text] [Related]  

  • 45. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 46. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
    Taylor LD; Dean FL; Tiedemann K; Ekert H
    Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radioimmunoassay of antihaemophilic factor (factor VIII) antigen.
    Paulssen MM; van de Graaf-Wildschut M; Kolhorn A; Planje MC
    Clin Chim Acta; 1975 Sep; 63(3):349-53. PubMed ID: 1080698
    [No Abstract]   [Full Text] [Related]  

  • 48. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of the platelet retention (von Willebrand) factor and its similarity to the antihemophilic factor (AHF).
    Weiss HJ; Rogers J; Brand H
    Blood; 1973 Jun; 41(6):809-15. PubMed ID: 4541271
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
    GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-haemophilic factor, normal and abnormal.
    Bennett B
    Br J Haematol; 1974 Jan; 26(1):1-7. PubMed ID: 4604099
    [No Abstract]   [Full Text] [Related]  

  • 53. Factor VIII (AHF) activity of small size produced by succinylating plasma.
    Barrow EM; Graham JB
    Am J Physiol; 1972 Jan; 222(1):134-41. PubMed ID: 4536749
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma antihemophilic factor biological and clinical aspects.
    BRINKHOUS KM
    Sang; 1954; 25(7):738-41. PubMed ID: 13225559
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hemophilia A with presence in the serum of a specific inhibitor of antihemophilic B globulin].
    STEFANOVIC S; ROLOVIC Z; BOZINOVIC L
    Hemostase; 1961 Jun; 1():135-41. PubMed ID: 13916528
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor VIII immunological assay. An evaluation of several methods using whole plasma.
    Girolami A; Sticchi A; Barbui T; Bareggi G
    Blut; 1974 Nov; 29(5):309-16. PubMed ID: 4214574
    [No Abstract]   [Full Text] [Related]  

  • 57. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
    SPAET TH; KINSELL BG
    Stanford Med Bull; 1954 Nov; 12(4):246-56. PubMed ID: 13225986
    [No Abstract]   [Full Text] [Related]  

  • 58. Implications of immunologic methods for measuring antihemophilic factor (factor VIII).
    Hoyer LW; Rick ME
    Ann N Y Acad Sci; 1975 Jan; 240():97-108. PubMed ID: 46140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-molecular-weight factor VIII.
    Weiss HJ
    Lancet; 1973 May; 1(7810):1000. PubMed ID: 4121555
    [No Abstract]   [Full Text] [Related]  

  • 60. [Study of the preservation of the A and B antihemophilic factors in lyophylized plasma].
    DUCOS J; BIERME R
    Rev Fr Etud Clin Biol; 1959 Dec; 4():1057-9. PubMed ID: 13818417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.